Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice

By sjmartinez • September 27, 2023

Teper Y, Ye L, Waldron RT, Lugea A, Sun X, Sinnett-Smith J, Hines OJ, Pandol SJ, Rozengurt E, Eibl G. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice. Sci Rep. 2023 Sep 26;13(1):16144. doi: 10.1038/s41598-023-43498-9. PMID: 37752238.

Tags: Cedars Sinai DoM, Digestive Diseases, Publications

Interaction between haploinsufficiency of PTPN2 and patient microbiome promotes autoimmune arthritis in mice

Sendo S, Vela AJ, Ro M, Thiruppathy D, Wilkinson EL, Zhao Z, Hsieh WC, Yang S, Coras R, Bergot AS, Guma M, Nguyen A, McBride[...]

A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi[...]

Menopause factors and alterations in gut microbiota and insulin homeostasis: A cross-sectional analysis of the microbiome and insulin longitudinal evaluation study (MILES)

Maffei VJ, Bertoni AG, Wood AC, Rotter JI, Crago O, Chen YI, Petrosino JF, Hoffman KL, Goodarzi MO, Jensen ET. Menopause factors and alterations in[...]